NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

On 18 April 2016, Recipharm announced that it had entered into two separate agreements to acquire pharmaceutical contract development and manufacturing operations (CDMO) from Kemwell. The first acquisition comprises operations in the US and Sweden, and the second acquisition comprises operations in India. The conditions for the first acquisition have…

news

A preliminary review by the U.S. Food and Drug Administration of Novo Nordisk A/S's experimental diabetes drug, IDegLira, questioned the interpretability of the study findings and practical utility of the treatment, according to a review posted on the agency's website on Friday. The review comes ahead of a May 24…

news

Glenmark Pharmaceuticals has received final approval from the US health regulator USFDA to sell Rufinamide, which is used to treat seizures caused by Lennox-Gastaut syndrome. "Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for its Rufinamide tablets," it said in a…

news

German drug giant Bayer said on Friday it was in talks to acquire US agriculture group Monsanto, after weeks of speculation about a possible tie-up. "Bayer executives recently met with executives of Monsanto to privately discuss a negotiated acquisition of Monsanto Company," the Leverkusen-based company said in a statement. "The…

news

Lupin has dipped almost 8% to Rs 1,525 on the BSE in early morning trade on the BSE, as analyst concerns about observations from the US drug regulator continue to remain an overhang for the near-term on the stock. Lupin had received USFDA 483’s for Goa plants with 9 observations…

news

Two new drugs that help the immune system fight some of the deadliest cancers are helping patients live years longer than older treatments, according to clinical trial results that should further boost confidence in this approach to oncology. Merck & Co showed that its Keytruda drug helped many patients with…

news

Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies. Several of India's generics producers, led by the country's second-largest player Dr Reddy's Laboratories Ltd , bet heavily on Venezuela as they…

news

South Texas Acclerated Research Therapeutics is spreading its global reach once again. The San Antonio-based organization, which already operates one of the largest Phase I medical onclogy programs in the world, has teamed with medical officials in Taiwan to create START Taipei. The new clinical site will be located on…

news

A clinical trial testing an experimental breast cancer pill from Novartis has been stopped early because of good results, boosting the Swiss company's efforts to build up its oncology business. The news puts Novartis on track to compete with a similar blockbuster product from Pfizer that is already on the…

news

The pharmaceutical sector is heading for a tough time as exports growth in formulations (in US dollar terms) is expected to almost halve to 10-12 per cent annually over the next five years, a report said. "Exports growth in formulations (in US dollar terms) is expected to decline sharply to…